Abstract
'UroLift' has emerged as a new minimally-invasive nonablative surgical technique for benign prostatic hyperplasia (BPH). We discuss the procedure, cost, evidence, advantages and disadvantages of this procedure. It is a novel technology suitable for a selected group of patients that allows for a bespoke treatment for men with BPH.
Cite
CITATION STYLE
APA
Jones, P., Rai, B. P., Aboumarzouk, O., & Somani, B. K. (2016, December 1). UroLift: A new minimally-invasive treatment for benign prostatic hyperplasia. Therapeutic Advances in Urology. SAGE Publications Inc. https://doi.org/10.1177/1756287216671497
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free